Clinical outcomes and microenvironment profiling of relapsed/refractory extramedullary disease of multiple myeloma patients with anti-BCMA CAR T cell-based therapy
Preprint in Research Square (April 2024)
The most recent citing publications are shown below. View all 28 publications that cite this research output on Dimensions.
Single-cell multiomic dissection of response and resistance to chimeric antigen receptor T cells against BCMA in relapsed multiple myeloma
Article in Nature Cancer (April 2024)
PD-1 downregulation enhances CAR-T cell antitumor efficiency by preserving a cell memory phenotype and reducing exhaustion
Article in Journal for ImmunoTherapy of Cancer (April 2024)